Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa

被引:122
|
作者
Kigozi, Isaac M.
Dobkin, Loren M. [1 ]
Martin, Jeffrey N. [2 ]
Geng, Elvin H. [1 ]
Muyindike, Winnie [3 ]
Emenyonu, Nneka I. [4 ]
Bangsberg, David R. [4 ]
Hahn, Judith A. [1 ]
机构
[1] Univ Calif San Francisco, Div Infect Dis, San Francisco Gen Hosp, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda
[4] Harvard Univ, Sch Med, Harvard Initiat Global Hlth, Massachusetts Gen Hosp, Boston, MA USA
基金
美国国家卫生研究院;
关键词
antiretroviral therapy; access; sub-Saharan Africa; late presentation; CD4 CELL COUNTS; LATE DIAGNOSIS; MEDICAL-CARE; HIV-1-INFECTED PATIENTS; SOUTH-AFRICA; COLLABORATIVE ANALYSIS; SEROSTATUS DISCLOSURE; ALCOHOL-CONSUMPTION; INFECTED PERSONS; UNITED-STATES;
D O I
10.1097/QAI.0b013e3181ab6eab
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Access to free antiretroviral therapy in sub-Saharan Africa has been steadily increasing, and the success of large-scale antiretroviral therapy programs depends on early initiation of HIV care. However, little is known about the stage at which those infected with HIV present for treatment in sub-Saharan Africa. Methods: We conducted a cross-sectional analysis of initial visits to the Immune Suppression Syndrome Clinic of the Mbarara University Teaching Hospital, including patients who had their initial visit between February 2007 and February 2008 (N = 2311). Results: The median age of the patients was 33 years (range 16-81 years), and 64% were female. More than one third (40%) were categorized as late presenters, that is, World Health Organization disease stage 3 or 4. Male gender, age 46-60 years (vs. younger), lower education level, being unemployed, living in a household with others, being unmarried, and lack of spousal HIV status disclosure were independently associated with late presentation, whereas being pregnant, having young children, and consuming alcohol in the prior year were associated with early presentation. Conclusions: Targeted public health interventions to facilitate earlier entry into HIV care are needed, as well as additional study to determine whether late presentation is due to delays in testing vs. delays in accessing care.
引用
收藏
页码:280 / 289
页数:10
相关论文
共 50 条
  • [1] Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa
    Wringe, Alison
    Floyd, Sian
    Kazooba, Patrick
    Mushati, Phyllis
    Baisley, Kathy
    Urassa, Mark
    Molesworth, Anna
    Schumacher, Christina
    Todd, Jim
    Zaba, Basia
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (08) : e38 - e48
  • [2] Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step
    Laurent, Christian
    JOURNAL OF PUBLIC HEALTH POLICY, 2010, 31 (04) : 401 - 406
  • [3] Patterns of uptake of HIV testing in sub-Saharan Africa in the pre-treatment era
    Cremin, Ide
    Cauchemez, Simon
    Garnett, Geoffrey P.
    Gregson, Simon
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (08) : e26 - e37
  • [4] Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?
    Zachariah, R.
    Harries, A. D.
    Philips, M.
    Arnould, L.
    Sabapathy, K.
    O'Brien, D. P.
    Ferreyra, C.
    Balkan, S.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2010, 104 (06) : 387 - 391
  • [5] Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa
    Kroeze, Stefanie
    Ondoa, Pascale
    Kityo, Cissy M.
    Siwale, Margaret
    Akanmu, Sulaimon
    Wellington, Maureen
    de Jager, Marleen
    Ive, Prudence
    Mandaliya, Kishor
    Stevens, Wendy
    Boender, T. Sonia
    de Pundert, Marieke E.
    Sigaloff, Kim C. E.
    Reiss, Peter
    Wit, Ferdinand W. N. M.
    de Wit, Tobias F. Rinke
    Hamers, Raph L.
    AIDS, 2018, 32 (08) : 1043 - 1051
  • [6] Liver disease in patients with HIV in sub-Saharan Africa
    Cainelli, Francesca
    Vento, Sandro
    LANCET HIV, 2015, 2 (10): : E412 - E413
  • [7] Determinants of antiretroviral therapy coverage in Sub-Saharan Africa
    Furuoka, Fumitaka
    Hoque, Mohammad Zahirul
    PEERJ, 2015, 3
  • [8] Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes
    Haas, Andreas D.
    Zaniewski, Elizabeth
    Anderegg, Nanina
    Ford, Nathan
    Fox, Matthew P.
    Vinikoor, Michael
    Dabis, Francois
    Nash, Denis
    Sinayobye, Jean d'Amour
    Niyongabo, Theodore
    Tanon, Aristophane
    Poda, Armel
    Adedimeji, Adebola A.
    Edmonds, Andrew
    Davies, Mary-Ann
    Egger, Matthias
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [9] Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Kebba, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) : 747 - 749
  • [10] Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa
    Harries, Anthony D.
    Zachariah, Rony
    Lawn, Stephen D.
    Rosen, Sydney
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 : 70 - 75